PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9016346-8	1997	These results demonstrate that the sensitivity to inhibition by NSAIDs of the 15-HETE production by ASA-treated PGHS-2 is different than that of prostaglandin production by PGHS-2 and that Ser516 plays an important role in the interaction with fenamate inhibitors.	Fenamates	244-252	prostaglandin-endoperoxide synthase 2	Homo sapiens	112-118	
11858641-3	2002	Molecular models of the complexes between indomethacin, fenamates, 2-phenylpropionic acids and the selective cyclooxygenase-2 (COX-2) inhibitors, with the cyclooxygenase active site of human PGHS-2 have been built by combining homology modelling, conformational searching and automated docking techniques.	Fenamates	56-65	prostaglandin-endoperoxide synthase 2	Homo sapiens	109-125	
11858641-3	2002	Molecular models of the complexes between indomethacin, fenamates, 2-phenylpropionic acids and the selective cyclooxygenase-2 (COX-2) inhibitors, with the cyclooxygenase active site of human PGHS-2 have been built by combining homology modelling, conformational searching and automated docking techniques.	Fenamates	56-65	prostaglandin-endoperoxide synthase 2	Homo sapiens	127-132	
29942156-7	2018	Fenamates were more active against cyclooxygenase-2 expressing BxPC-3 than cyclooxygenase-2 non-expressing MIA PaCa-2 cell line.	Fenamates	0-9	prostaglandin-endoperoxide synthase 2	Homo sapiens	35-51	
29942156-7	2018	Fenamates were more active against cyclooxygenase-2 expressing BxPC-3 than cyclooxygenase-2 non-expressing MIA PaCa-2 cell line.	Fenamates	0-9	prostaglandin-endoperoxide synthase 2	Homo sapiens	75-91